课题基金 / 基金详情

MyVaccineRegister - App/Portal to declare an individual's vaccination against and immunity to COVID-19

MyVaccineRegister - App/Portal to declare an individual's vaccination against and immunity to COVID-19
MyVaccineRegister - 用于声明个人已接种 COVID-19 疫苗并具有免疫力的应用程序/门户
批准号:
60715
负责人:
金额:
$9.53万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The ImmucheX solution is a real-time verified database for each country of individuals who have received a COVID-19 vaccine, who have subsequently been tested for and registered as having immunity to the virus; this is in contrast to the concept of herd immunity - where a subject has been exposed to the virus but not necessarily generated long-term immunity. It will enable registered individuals to return to normal work and not be affected by coming into contact with the virus, whatever the transmission mechanism. It also deals with the issues of social distancing - since a person who has been vaccinated not only protects themselves, but also reduces the risk of onward transmission.The ImmucheX project is designed to work within a government's health/citizen identity systems and any registered vaccine for that country. Given that there are several vaccines globally, there may be more than one registered vaccine in each country. The ImmucheX solution is designed to work across any of these vaccines.A key objective is that the platform should be open to all nations and it will need to deliver data accurately and speedily.The access to an accurate vaccination record and immunity, verified and digitally delivered, will enable the world to live with COVID-19. Access for the individual is to be via the ImmucheX mobile App (Android/iOS platforms) which they will use to prove their immunity. The ImmucheX App has been designed with privacy first and does not collect data - it is simply to prove an individual's immunity by vaccination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于单细胞和空间转录组分析APP-CD74在衰老泪腺中介导免疫微环境紊乱的机制研究
  • 批准号:
    2026JJ50085
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王万鹏
  • 依托单位:
基于GPX4/ACSL4铁死亡通路的 APP 基因突变调控 Aβ 代谢异常在阿尔茨海默病中的作用机制研究
  • 批准号:
    JCZRLH202600691
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
DDAH2在小胶质细胞中调控APP蛋白代谢的新机制及其在阿尔兹海默症中的作用
  • 批准号:
    2026JJ80535
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李俊杰
  • 依托单位:
APP细胞间信号介导癌症干细胞与肿瘤细胞的互作驱动肾癌干性特征和肿瘤发生发展的机制研究